Continuous subcutaneous insulin infusion: experience from a large specialist service

The National Institute for Health and Clinical Excellence issued guidelines on continuous subcutaneous insulin infusion (CSII) in 2003 and has recently updated them. We present the findings of a retrospective study on CSII in a tertiary teaching hospital. Data were analysed on 85 patients establishe...

Full description

Saved in:
Bibliographic Details
Published in:Practical diabetes international 2009-03, Vol.26 (2), p.60-64
Main Authors: Chellamuthu, P, Lawrence, IG, Kitchener, D, McNally, PG, Gregory, R, Jackson, S, Kong, M-F, Jarvis, J, Davies, MJ
Format: Article
Language:English
Subjects:
audit
CSII
diabetes mellitus
insulin pump therapy
NICE guidance
patient education
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The National Institute for Health and Clinical Excellence issued guidelines on continuous subcutaneous insulin infusion (CSII) in 2003 and has recently updated them. We present the findings of a retrospective study on CSII in a tertiary teaching hospital. Data were analysed on 85 patients established on CSII. The mean follow up was 24 months, 70% were female and the mean age was 40 years. Eighty‐two patients (96.5%) had type 1 diabetes, the mean duration of diabetes being 23 years, and NICE guidelines were followed for initiation in 78%. Patient satisfaction was assessed by Likert scale (‐3 to + 3) questionnaire. On CSII there was an improvement in HbA1c (mean [SD] 9.4[1.9] vs 8.6[1.5]%; [p
ISSN:1357-8170
1528-252X
DOI:10.1002/pdi.1337